| scholarly article | Q13442814 |
| P2093 | author name string | S Igarashi | |
| C Cho | |||
| K-C Yong | |||
| L-W Lai | |||
| Y-Hh Lien | |||
| P2860 | cites work | Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate | Q22010773 |
| Lysophospholipids--receptor revelations | Q28208260 | ||
| Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice | Q28239258 | ||
| F4/80, a monoclonal antibody directed specifically against the mouse macrophage | Q28281328 | ||
| Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure | Q28364539 | ||
| Tumor necrosis factor- induces adhesion molecule expression through the sphingosine kinase pathway | Q29041393 | ||
| Adhesion receptors of the immune system | Q29616393 | ||
| Chemokines--chemotactic cytokines that mediate inflammation | Q29616433 | ||
| Sphingosine-1-phosphate: an enigmatic signalling lipid | Q29620563 | ||
| A(2A) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion | Q30306294 | ||
| Cell adhesion molecules and the glomerulopathies | Q33754514 | ||
| Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors | Q34691444 | ||
| Recent advances in the pathophysiology of ischemic acute renal failure | Q35182393 | ||
| Pathogenesis of renal ischemia/reperfusion injury: lessons from knockout mice | Q35586494 | ||
| Leukocyte recruitment and acute renal failure | Q35605546 | ||
| FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. | Q35804361 | ||
| Inflammatory cells in ischemic acute renal failure | Q35836384 | ||
| Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure | Q36169286 | ||
| Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network | Q36184401 | ||
| Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury | Q37352075 | ||
| The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury | Q37371904 | ||
| S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate | Q40405662 | ||
| Stable knock-down of the sphingosine 1-phosphate receptor S1P1 influences multiple functions of human endothelial cells. | Q40477230 | ||
| The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80. Relationship between macrophages, Langerhans cells, reticular cells, and dendritic cells in lymphoid and hematopoietic organs. | Q42157572 | ||
| Prevention of renal ischemic reperfusion injury using FTY 720 and ICAM-1 antisense oligonucleotides | Q42443655 | ||
| FTY 720 prevents ischemic reperfusion damage in rat kidneys | Q43552719 | ||
| Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2. | Q44385104 | ||
| Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate | Q44734550 | ||
| FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury | Q44761573 | ||
| Sphingosine kinase-1 mediates TNF-alpha-induced MCP-1 gene expression in endothelial cells: upregulation by oscillatory flow | Q44932366 | ||
| Renal medullary gene expression in aquaporin-1 null mice | Q45126779 | ||
| Determination of serum creatinine by a direct colorimetric method | Q48010258 | ||
| Effect of thiazide on renal gene expression of apical calcium channels and calbindins. | Q54709203 | ||
| Early renal ischemia, with or without reperfusion, activates NFkappaB and increases TNF-alpha bioactivity in the kidney | Q73593555 | ||
| Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice | Q74247708 | ||
| TNF-alpha-dependent bilateral renal injury is induced by unilateral renal ischemia-reperfusion | Q77481030 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1601-1608 | |
| P577 | publication date | 2006-05-01 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | S1P(1)-selective agonist, SEW2871, ameliorates ischemic acute renal failure. | |
| P478 | volume | 69 |
| Q34593159 | "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets |
| Q50074651 | A selective sphingosine-1-phosphate receptor 1 agonist SEW-2871 aggravates gastric cancer by recruiting myeloid-derived suppressor cells |
| Q80008160 | A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia-reperfusion injury |
| Q40488333 | Activation of sphingosine 1-phosphate receptor-1 by SEW2871 improves cognitive function in Alzheimer's disease model rats |
| Q30432124 | Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury |
| Q33810644 | Advances in understanding ischemic acute kidney injury |
| Q30277374 | Cellular and Molecular Mechanisms of AKI. |
| Q35684358 | Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules |
| Q37154389 | Cholinergic agonists attenuate renal ischemia-reperfusion injury in rats. |
| Q30427148 | Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes |
| Q36764024 | Current perspectives on FTY720. |
| Q30439331 | Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury |
| Q30275541 | Endothelial Sphingosine 1‑Phosphate Receptor‑1 Mediates Protection and Recovery from Acute Kidney Injury |
| Q37657227 | FTY720 Attenuates Angiotensin II-Induced Podocyte Damage via Inhibiting Inflammatory Cytokines. |
| Q34162426 | FTY720 Regulates Bone Marrow Egress of Eosinophils and Modulates Late-Phase Skin Reaction in Mice |
| Q42696824 | Heart-kidney crosstalk and role of humoral signaling in critical illness |
| Q38876000 | Identification of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P1) as a Pathogenic Factor in Transient Focal Cerebral Ischemia |
| Q30434767 | Immune mechanisms and novel pharmacological therapies of acute kidney injury |
| Q37991781 | Immunotherapy for acute kidney injury |
| Q35715879 | Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury |
| Q34490320 | Ischemic preconditioning in the liver is independent of regulatory T cell activity |
| Q34501876 | Isoflurane activates intestinal sphingosine kinase to protect against bilateral nephrectomy-induced liver and intestine dysfunction |
| Q36833331 | Isoflurane activates intestinal sphingosine kinase to protect against renal ischemia-reperfusion-induced liver and intestine injury |
| Q40075805 | Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate-dependent pathways |
| Q33808769 | Isoflurane protects human kidney proximal tubule cells against necrosis via sphingosine kinase and sphingosine-1-phosphate generation |
| Q37029951 | Knockout of interleukin-17A protects against sepsis-associated acute kidney injury |
| Q37332688 | Lymphocytes and ischemia-reperfusion injury |
| Q33829692 | Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget |
| Q37698228 | Mediators of inflammation in acute kidney injury |
| Q37187014 | Mesenchymal stem cells attenuate ischemic acute kidney injury by inducing regulatory T cells through splenocyte interactions |
| Q34458426 | Modulation of Chemokines and Allergic Airway Inflammation by Selective Local Sphingosine-1-phosphate Receptor 1 Agonism in Lungs |
| Q36877881 | Nicotinic acetylcholine receptor expression and regulation in the rat kidney after ischemia-reperfusion injury |
| Q47099705 | Novel Therapies for Acute Kidney Injury |
| Q37014196 | Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review |
| Q38083851 | Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury |
| Q87417830 | Oral treatment with SEW2871, a sphingosine-1-phosphate type 1 receptor agonist, ameliorates experimental colitis in interleukin-10 gene deficient mice |
| Q37980790 | Perspectives on immunomodulation early in life. |
| Q35923305 | Pharmacologic recruitment of regulatory T cells as a therapy for ischemic acute kidney injury |
| Q35130512 | Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system |
| Q79326960 | Plasma creatinine determination in mice and rats: an enzymatic method compares favorably with a high-performance liquid chromatography assay |
| Q43180478 | Protective effects of Nigella sativa against ischemia-reperfusion injury of kidneys |
| Q46024801 | Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion. |
| Q36237338 | Proximal tubule sphingosine kinase-1 has a critical role in A1 adenosine receptor-mediated renal protection from ischemia. |
| Q30435312 | Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury |
| Q53644116 | SEW2871 protects from experimental colitis through reduced epithelial cell apoptosis and improved barrier function in interleukin-10 gene-deficient mice. |
| Q38262413 | Selective deletion of the endothelial sphingosine-1-phosphate 1 receptor exacerbates kidney ischemia-reperfusion injury |
| Q36725207 | Site-specific expression of IQGAP1, a key mediator of cytoskeleton, in mouse renal tubules |
| Q37480008 | Sphinganine-1-phosphate attenuates both hepatic and renal injury induced by hepatic ischemia and reperfusion in mice |
| Q34430282 | Sphinganine-1-phosphate protects kidney and liver after hepatic ischemia and reperfusion in mice through S1P1 receptor activation |
| Q37162539 | Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction |
| Q55311906 | Sphingosine 1-Phosphate Receptor 1 Is Required for MMP-2 Function in Bone Marrow Mesenchymal Stromal Cells: Implications for Cytoskeleton Assembly and Proliferation. |
| Q37551932 | Sphingosine 1-Phosphate Receptor Modulators and Drug Discovery |
| Q33753317 | Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis? |
| Q30425603 | Sphingosine 1-phosphate chemical biology |
| Q39488891 | Sphingosine kinase 1 protects against renal ischemia-reperfusion injury in mice by sphingosine-1-phosphate1 receptor activation |
| Q92405275 | Sphingosine-1-Phosphate and Macrophage Biology-How the Sphinx Tames the Big Eater |
| Q36759605 | Sphingosine-1-phosphate and FTY720 as anti-atherosclerotic lipid compounds |
| Q30440476 | Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease |
| Q44125780 | Sphingosine-1-phosphate signalling induces the production of Lcn-2 by macrophages to promote kidney regeneration |
| Q33757076 | Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema |
| Q30439643 | Targeting sphingosine 1 phosphate receptor type 1 receptors in acute kidney injury |
| Q39379449 | Targeting sphingosine-1-phosphate signaling for cancer therapy |
| Q34364844 | Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond |
| Q43108535 | The antioxidant role of oral administration of garlic oil on renal ischemia-reperfusion injury. |
Search more.